Key Highlights

  • Helen of Troy (Nasdaq: HELE) rose about 10.4% at last closing after Q1 FY27 net sales of $402.1 million (+8.2%, organic +7.4%) and adjusted EPS of $0.17 beat lowered estimates.
  • Margins stayed pressured: adjusted EBITDA margin slipped to 6.3% and gross margin fell about 110 basis points to 46.0%, hurt by China-sourcing tariffs; GAAP EPS of $1.51 reflected non-recurring items.
  • Debt fell to $716.1 million and net leverage improved to 3.48x, with FY27 guidance of $1.759-$1.831 billion sales and $3.25-$3.75 adjusted EPS, but negative Q1 free cash flow keeps the turnaround unproven.
  • Three questions will likely shape whether this quarter marks a turn or a bounce.

A sales beat lifts a battered consumer name

Helen of Troy Limited (NASDAQ:HELE), the Nasdaq-listed consumer-products company behind OXO, Hydro Flask, Osprey, Braun, Honeywell air treatment and Drybar, jumped after reporting first-quarter fiscal 2027 results that cleared a low bar Wall Street had set for it. According to MarketBeat, the shares climbed about 10.4% at last closing, trading as high as $28.40 from a prior close near $25.17. The gainers list showing HELE up roughly 6% is consistent with that post-earnings pop, capturing part of the same move rather than a separate event.

The catalyst is verifiable. Helen of Troy filed an 8-K carrying the results (accession 0000916789-26-000094), and the numbers beat depressed expectations on both the top and bottom lines. The reaction says as much about how far sentiment had fallen as about the quarter itself. This is a company that has spent two years cutting debt, reshuffling its brand portfolio and cycling through senior leadership while discretionary demand stayed soft.

Inside the quarter: growth returns, margins do not

For the period ended consolidated net sales rose 8.2% to $402.1 million, with organic sales up 7.4%. That topped analyst revenue estimates that clustered in the high-$360 million to mid-$370 million range, a beat of roughly 8% to 9% depending on the source. After several quarters of organic declines, a return to positive organic growth is the headline number that appears to have moved the stock.

Both segments contributed. Home & Outdoor sales grew 9.5% to $194.9 million, helped by international demand and new product launches. Beauty & Wellness rose 7.0% to $207.2 million, with strength in nail-care and seasonal categories such as fans and thermometers. International sales rose about 1.1%, a reminder that the recovery is being led by the domestic and product-launch side of the business rather than a broad geographic upturn.

Profitability told a more cautious story. Adjusted diluted EPS came in at $0.17, down sharply from $0.41 a year earlier but well ahead of a consensus that, by several accounts, had penciled in a small loss or roughly break-even. Adjusted EBITDA was $25.5 million, a 6.3% margin that slipped from 6.9% the prior year. Gross margin fell about 110 basis points to 46.0%, pressured by tariffs and mix. In short, Helen of Troy sold more than expected but earned less on each dollar, and the market appeared willing to reward the growth surprise while looking past the margin erosion.

One figure deserves a caveat. GAAP diluted EPS was reported at $1.51, far above the $0.17 adjusted measure. That gap reflects items management strips out of its adjusted results; the wide spread suggests non-recurring gains flattered the GAAP line, so the adjusted number is the cleaner read on underlying operations. Readers should treat the $1.51 as a bookkeeping outcome rather than evidence of a sudden earnings turnaround.

Guidance and the leverage question

Management paired the beat with a full-year outlook that frames fiscal 2027 as a rebuild rather than a breakout. The company guided to net sales of $1.759 billion to $1.831 billion, adjusted diluted EPS of $3.25 to $3.75, adjusted EBITDA of $190 million to $197 million, and free cash flow of $85 million to $100 million. It also pointed to a net leverage ratio of roughly 3.2x or lower by year-end.

The outlook also breaks down by segment. Coverage of the results indicated Home & Outdoor guidance in the range of about $859 million to $884 million and Beauty & Wellness of roughly $900 million to $947 million, implying management expects both units to keep growing modestly through the year rather than leaning on a single division to carry the recovery.

Balance-sheet repair remains central to the story. Total debt fell to $716.1 million from $871.0 million a year earlier, and net leverage improved to 3.48x from 3.87x in the prior quarter, according to results coverage. That progress matters because leverage has been the overhang that magnifies every swing in demand: with a debt load of that size against sub-$200 million EBITDA, the company has limited room for error. The guided path back toward roughly 3x would give management more breathing space, though it depends on the free-cash-flow targets holding.

The near-term cash picture was less flattering. First-quarter free cash flow was negative $6.4 million, a swing from positive $45.0 million a year earlier, reflecting working-capital timing and the seasonal shape of the business. That makes the full-year free-cash-flow guide the number to watch: the deleveraging thesis rests on cash generation reaccelerating over the balance of the year. It also leaves little margin for a demand disappointment in the back half.

Tariffs and the China problem

Tariffs are the recurring drag on Helen of Troy's margins, and the quarter did nothing to dispel that. The company sources a meaningful share of its products from China, which leaves it directly exposed to US import duties on categories spanning kitchen tools, personal-care appliances and hydration gear. The roughly 110-basis-point gross-margin decline was attributed in part to a net unfavorable tariff impact, and results coverage cited around $15 million of tariff-related costs sitting in inventory that will flow through future cost of goods.

There were offsets. Helen of Troy recognized about a $1.8 million benefit tied to phase-one tariff refunds during the quarter and indicated roughly $9.2 million of such refunds may be collectible over the full year. Those recoveries help at the margin but do not change the structural reality: until the company further diversifies its supply chain away from China or pushes through pricing that sticks, tariffs will keep pressuring gross margin. Management has discussed supplier diversification, and the pace of that shift is a key variable for the margin recovery embedded in guidance.

The demand backdrop compounds the challenge. Helen of Troy sells largely discretionary household and personal goods, the kind of purchases consumers defer or trade down on when budgets tighten. A sales beat against lowered estimates is encouraging, but it does not by itself signal that the discretionary spending environment has durably improved.

A new management team, an unfinished turnaround

The quarter is also a test for a relatively new leadership group. G. Scott Uzzell, whose employment agreement was disclosed in an August 2025 8-K, is running the company as chief executive, with Brian Grass, named under a May 2025 agreement, as chief financial officer. In the release, Uzzell characterized fiscal 2027 as off to a solid start with first-quarter sales and adjusted EPS above expectations, while acknowledging meaningful work ahead in what he described as a dynamic operating environment.

That framing fits a company still executing on efficiency and portfolio initiatives. Helen of Troy launched a restructuring program branded Project Pegasus in 2022 and has more recently described a strategy it calls Elevate for Growth aimed at sharpening its brands, getting closer to consumers and tightening operations. The latest release emphasized similar themes rather than new program specifics, so investors should read the current quarter as continuity of that turnaround work rather than a fresh strategic pivot. The company has also reshaped its portfolio over time through acquisitions and divestitures, including a facility sale that contributed to the debt reduction.

Bermuda incorporation is a structural detail worth noting for context. Helen of Troy is organized in Bermuda and classified under the electric-housewares industry in SEC filings, and it trades on Nasdaq. The offshore structure has historically supported a lower effective tax rate, one of the few tailwinds in a model otherwise squeezed by tariffs and soft demand.

Conclusion

The market's enthusiasm on July 9 rewarded a genuine positive surprise, but the setup remains delicate. Analysts, for their part, have stayed cautious: coverage cited a consensus that leans toward hold-type ratings with price targets clustered in the mid-$20s, and at least one firm nudged its target higher while keeping a neutral stance after the print. That is a reminder that a single beat has not yet reset the longer-run narrative in the eyes of the sell side.

Three questions will likely shape whether this quarter marks a turn or a bounce. First, can organic growth stay positive as the year progresses, or was the first-quarter strength partly a function of product-launch timing and easy comparisons? Second, does free cash flow rebound enough to keep the deleveraging plan on track toward roughly 3.2x? Third, how much more margin can tariffs take before pricing or supply-chain diversification catches up?

For now, Helen of Troy has bought itself credibility by beating a bar it had repeatedly missed. The organic-growth inflection and continued debt reduction are real positives. Whether they add up to a sustained recovery, or simply a better-than-feared quarter in a still-difficult market, is the question the next several reports will answer. Investors weighing the name will want to see the margin and cash-flow trends confirm the top-line improvement before concluding the turnaround has taken hold.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.